title: Management of a patient with borderline resectable pancreatic cancer. Case report and review.
abstract: The definition and management of borderline resectability for periampullary pancreatic adenocarcinoma are evolving. In this case report, we discuss the presentation, workup, and therapeutic management of a 40-year-old man who presented with borderline resectable, periampullary pancreatic cancer and underwent a margin-negative resection following neoadjuvant chemoradiotherapy.
authors.affiliation: Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois 60612, USA.
authors.forename: Anand P
authors.initials: AP
authors.lastname: Shah
authors.forename: Jonathan B
authors.initials: JB
authors.lastname: Strauss
authors.forename: William T
authors.initials: WT
authors.lastname: Leslie
authors.forename: Amar
authors.initials: A
authors.lastname: Shah
authors.forename: Brett
authors.initials: B
authors.lastname: Mahon
authors.forename: Ross A
authors.initials: RA
authors.lastname: Abrams
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D000328:Adult; D014670:Ampulla of Vater; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016577:Pancreaticoduodenectomy; D011182:Postoperative Care; D011300:Preoperative Care; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine